Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Hyunil Jo
Affiliation
Department of Pharmaceutical Chemistry, University of California San Francisco
ORCID
Career Start Year
2002
Papers
39
H Index
20
Expertise
CM4AI Collaborator
Andrej Sali (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36824741
Designed Transmembrane Proteins Inhibit the Erythropoietin Receptor in a Custom Binding Topology.
bioRxiv
2023
37632140
Hexamethylene amiloride binds the SARS-CoV-2 envelope protein at the protein-lipid interface.
Protein Sci
2023
38014268
<i>De novo</i> Design of Peptides that Bind Specific Conformers of α-Synuclein.
bioRxiv
2023
37425793
Patterning and folding of intestinal villi by active mesenchymal dewetting.
bioRxiv
2023
35080027
Brilacidin, a COVID-19 drug candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell.
J Med Virol
2022
36219675
SARS-CoV-2 Envelope Protein Forms Clustered Pentamers in Lipid Bilayers.
Biochemistry
2022
35082148
Soluble TREM2 inhibits secondary nucleation of Aβ fibrillization and enhances cellular uptake of fibrillar Aβ.
Proc Natl Acad Sci U S A
2022
33956668
Integrin α2β1 regulates collagen I tethering to modulate hyperresponsiveness in reactive airway disease models.
J Clin Invest
2021
34010565
Visualization of Platelet Integrins via Two-Photon Microscopy Using Anti-transmembrane Domain Peptides Containing a Blue Fluorescent Amino Acid.
Biochemistry
2021
33007395
Dual antagonists of α5β1/αvβ1 integrin for airway hyperresponsiveness.
Bioorg Med Chem Lett
2020
30957824
Synthesis and application of the blue fluorescent amino acid l-4-cyanotryptophan to assess peptide-membrane interactions.
Chem Commun (Camb)
2019
30744004
4-Cyanoindole-2'-deoxyribonucleoside as a Dual Fluorescence and Infrared Probe of DNA Structure and Dynamics.
Molecules
2019
30998340
Glutamine Side Chain <sup>13</sup>Câ¿<sup>18</sup>O as a Nonperturbative IR Probe of Amyloid Fibril Hydration and Assembly.
J Am Chem Soc
2019
29417711
Design of a Short Thermally Stable α-Helix Embedded in a Macrocycle.
Chembiochem
2018
30102523
Entry from the Lipid Bilayer: A Possible Pathway for Inhibition of a Peptide G Protein-Coupled Receptor by a Lipophilic Small Molecule.
Biochemistry
2018
30532032
Inhibitor binding mode and allosteric regulation of Na<sup>+</sup>-glucose symporters.
Nat Commun
2018
27918306
Targeting integrin α5β1 ameliorates severe airway hyperresponsiveness in experimental asthma.
J Clin Invest
2017
28278376
Stapled Voltage-Gated Calcium Channel (Ca<sub>V</sub>) α-Interaction Domain (AID) Peptides Act As Selective Protein-Protein Interaction Inhibitors of Ca<sub>V</sub> Function.
ACS Chem Neurosci
2017
28406028
Water Distribution, Dynamics, and Interactions with Alzheimer's β-Amyloid Fibrils Investigated by Solid-State NMR.
J Am Chem Soc
2017
28220032
Pharmacologic Blockade of <i>α</i>v<i>β</i>1 Integrin Ameliorates Renal Failure and Fibrosis <i>In Vivo</i>.
J Am Soc Nephrol
2017
28533371
Blue fluorescent amino acid for biological spectroscopy and microscopy.
Proc Natl Acad Sci U S A
2017
27220724
Photoactivatable protein labeling by singlet oxygen mediated reactions.
Bioorg Med Chem Lett
2016
27725984
Infrared and fluorescence assessment of the hydration status of the tryptophan gate in the influenza A M2 proton channel.
Phys Chem Chem Phys
2016
27774126
Exploring <i>N</i>-Arylsulfonyl-l-proline Scaffold as a Platform for Potent and Selective αvβ1 Integrin Inhibitors.
ACS Med Chem Lett
2016
27414264
Structural Polymorphism of Alzheimer's β-Amyloid Fibrils as Controlled by an E22 Switch: A Solid-State NMR Study.
J Am Chem Soc
2016
25995225
The αvβ1 integrin plays a critical in vivo role in tissue fibrosis.
Sci Transl Med
2015
25470189
Flipping in the pore: discovery of dual inhibitors that bind in different orientations to the wild-type versus the amantadine-resistant S31N mutant of the influenza A virus M2 proton channel.
J Am Chem Soc
2014
23437766
Discovery of novel dual inhibitors of the wild-type and the most prevalent drug-resistant mutant, S31N, of the M2 proton channel from influenza A virus.
J Med Chem
2013
24205975
Assessment of local friction in protein folding dynamics using a helix cross-linker.
J Phys Chem B
2013
22210111
Affinity of talin-1 for the β3-integrin cytosolic domain is modulated by its phospholipid bilayer environment.
Proc Natl Acad Sci U S A
2012
23245326
Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials.
Cell Host Microbe
2012
22998171
Development of α-helical calpain probes by mimicking a natural protein-protein interaction.
J Am Chem Soc
2012
22440900
Inhibition of integrin α2β1 ameliorates glomerular injury.
J Am Soc Nephrol
2012
22540162
Using thioamides to site-specifically interrogate the dynamics of hydrogen bond formation in β-sheet folding.
J Am Chem Soc
2012
20547797
Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay.
Antimicrob Agents Chemother
2010
21077670
Selective incorporation of nitrile-based infrared probes into proteins via cysteine alkylation.
Biochemistry
2010
19301922
An unusual pathway to cyclobutane formation via desulfurative intramolecular photocycloaddition of an enone benzothiazoline pair.
Org Lett
2009
15624981
Highly stereoselective and efficient total synthesis of (+)-laurencin.
Org Lett
2005
11856018
Asymmetric total synthesis of (+)-brefeldin A from (S)-lactate by triple chirality transfer process and nitrile oxide cycloaddition.
J Org Chem
2002
1 - 39 of 39
Column Actions
Search
Recommended Authors
Michael J Robertson
Stanford University School of Medicine
Career Start Year
2015
Number of shared co-authors
0
Zhi Lin
Shanghai Jiao Tong University
Career Start Year
2012
Number of shared co-authors
1
Daniel Carbajo
Institut de Quimica Avancada de Catalunya (IQAC-CSIC)
Career Start Year
2011
Number of shared co-authors
0
Amit Choudhary
Broad Institute of MIT and Harvard
Career Start Year
2009
Number of shared co-authors
0
Xiaofei Jia
University of Massachusetts Dartmouth
Career Start Year
2008
Number of shared co-authors
1
Andrew C Kruse
Blavatnik Institute, Harvard Medical School
Career Start Year
2008
Number of shared co-authors
2
Nir London
The Weizmann Institute of Science
Career Start Year
2007
Number of shared co-authors
4
Suwen Zhao
ShanghaiTech University, China iHuman Institute
Career Start Year
2006
Number of shared co-authors
3
Jianwei Che
Dana-Farber Cancer Institute
Career Start Year
2005
Number of shared co-authors
0
Priyadarshini Jaishankar
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year
2005
Number of shared co-authors
1
Andrew B Waight
Merck & Co.
Career Start Year
2003
Number of shared co-authors
1
Jason E Gestwicki
Institute for Neurodegenerative Diseases, University of California San Francisco
Career Start Year
2000
Number of shared co-authors
7
R Scott Lokey
University of California Santa Cruz
Career Start Year
2000
Number of shared co-authors
2
Udupi A Ramagopal
Poornaprajna Institute of Scientific Research (PPISR)
Career Start Year
1998
Number of shared co-authors
1
Pavel Strop
Pfizer Inc.
Career Start Year
1997
Number of shared co-authors
1
Soumya S Ray
Lysosomal Therapeutics Inc.
Career Start Year
1997
Number of shared co-authors
1
Rodrigo J Carbajo
Oncology R&D
Career Start Year
1997
Number of shared co-authors
1
Adam R Renslo
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year
1997
Number of shared co-authors
6
Jack Taunton
University of California san francisco
Career Start Year
1996
Number of shared co-authors
6
Witek Kwiatkowski
Swiss Federal Institute of Technology
Career Start Year
1996
Number of shared co-authors
2
Hualiang Jiang
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
Career Start Year
1994
Number of shared co-authors
0
Dieter Willbold
Institute of Physical Biology, Heinrich Heine University Dusseldorf
Career Start Year
1993
Number of shared co-authors
1
Steven C Almo
Albert Einstein College of Medicine
Career Start Year
1988
Number of shared co-authors
3
Raymond C Stevens
iHuman Institute, ShanghaiTech University
Career Start Year
1988
Number of shared co-authors
1
Laura L Kiessling
Massachusetts Institute of Technology
Career Start Year
1987
Number of shared co-authors
0
Ronald T Raines
Massachusetts Institute of Technology
Career Start Year
1981
Number of shared co-authors
0
Ruben Abagyan
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year
1981
Number of shared co-authors
0
James A Wells
Department of Pharmaceutical Chemistry, University of California San Francisco
Career Start Year
1974
Number of shared co-authors
6
Horst Kessler
Institute for Advanced Study, Technical University Munich
Career Start Year
1966
Number of shared co-authors
2
Jens Meiler
Vanderbilt University
Career Start Year
1954
Number of shared co-authors
3
row(s) 1 - 30 of 30
Collaborators
William F DeGrado
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers
35
Aparna Sundaram
Formerly with the Guttmacher Institute.
Co-authored papers
3
Haifan Wu
Wichita State University
Co-authored papers
3
Huong T Kratochvil
Department of Pharmaceutical Chemistry, University of California-San Francisco
Co-authored papers
3
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers
2
Thomas Lemmin
Co-authored papers
2
Carlo Condello
UCSF Weill Institute for Neurosciences, University of California san francisco
Co-authored papers
2
Shaun R Coughlin
Co-authored papers
1
Erika Castillo
Institute for Neurodegenerative Diseases, University of California san francisco
Co-authored papers
1
Paola Bisignano
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Co-authored papers
1
Daniel J Saltzberg
University of California san francisco
Co-authored papers
1
David E Shaw
Columbia University
Co-authored papers
1
Kala Bharath Pilla
Quantitative Biology Institute, University of California san francisco
Co-authored papers
1
Daniel L Minor
Cardiovascular Research Institute, University of California san francisco
Co-authored papers
1
Kathleen S Molnar
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers
1
Ji Jin
College of Life Sciences and Medicine, Zhejiang Sci-Tech University
Co-authored papers
1
Xiaokun Shu
Co-authored papers
1
Jan St??hr
Weill Institute for Neurosciences, University of California san francisco
Co-authored papers
1
Stanley B Prusiner
Weill Institute for Neurosciences, University of California San Francisco
Co-authored papers
1
Annalise Bond
Institute for Neurodegenerative Diseases, University of California san francisco
Co-authored papers
1
Matthew P Jacobson
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers
1
Chakrapani Kalyanaraman
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers
1
Matt Thomson
California Institute of Technology
Co-authored papers
1
Melissa S Love
a Division of The Scripps Research Institute
Co-authored papers
1
John W Weisel
University of Pennsylvania
Co-authored papers
1
Ketaki D Belsare
The University of Chicago
Co-authored papers
1
Addison E Roush
Co-authored papers
1
Alma L Burlingame
Department of Pharmaceutical Chemistry, University of California san francisco
Co-authored papers
1
1 - 28